EPS for Guyana Goldfields Inc. (GUY) Expected At $0.10; Spectranetics (SPNC) Sentiment Is 1.39

October 30, 2017 - By Migdalia James

The Spectranetics Corporation develops, makes, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The company has market cap of $1.68 billion. The Company’s products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads. It currently has negative earnings. The Company’s geographic divisions are U.S.

Analysts expect Guyana Goldfields Inc. (TSE:GUY) to report $0.10 EPS on November, 9.They anticipate $0.04 EPS change or 66.67% from last quarter’s $0.06 EPS. T_GUY’s profit would be $17.27 million giving it 10.65 P/E if the $0.10 EPS is correct. After having $-0.03 EPS previously, Guyana Goldfields Inc.’s analysts see -433.33% EPS growth. About 80,362 shares traded. Guyana Goldfields Inc. (TSE:GUY) has 0.00% since October 30, 2016 and is . It has underperformed by 16.70% the S&P500.

Ratings analysis reveals 100% of Spectranetics’s analysts are positive. Out of 2 Wall Street analysts rating Spectranetics, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. SPNC was included in 2 notes of analysts from October 21, 2016. The firm has “Outperform” rating by Raymond James given on Friday, December 16. The company was maintained on Friday, October 21 by Needham.

Wellington Shields & Co. Llc holds 4.25% of its portfolio in Spectranetics Corp for 320,300 shares. Harvest Management Llc owns 112,710 shares or 2.89% of their US portfolio. Moreover, First Light Asset Management Llc has 2.8% invested in the company for 217,637 shares. The New York-based Iguana Healthcare Management Llc has invested 2.39% in the stock. Oak Ridge Investments Llc, a Illinois-based fund reported 1.92 million shares.

It closed at $38.45 lastly. It is down 67.37% since October 30, 2016 and is uptrending. It has outperformed by 50.67% the S&P500.